| # | Drug | Count |
|---|---|---|
| 0 | LAMIVUDINE | 18 |
| 1 | LAMIVUDINE ORAL | 18 |
| 2 | TENOFOVIR DISOPROXIL FUMARATE | 14 |
| 3 | TENOFOVIR DISOPROXIL FUMARATE TABLETS | 14 |
| 4 | ZIDOVUDINE | 8 |
| 5 | EMTRICITABINE | 4 |
| 6 | RALTEGRAVIR | 2 |
| 7 | ASPIRIN | 1 |
| 8 | ASPIRIN 325 MG | 1 |
| 9 | ASPIRIN 81 MG | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DORAVIRINE, LAMIVUDINE, AND TENOFOVIR DISOPROXIL FUMARATE | 1 | 0.0032 |
| 1 | TENOFOVIR DISOPROXIL FUMARATE TABLETS | 14 | 0.0016 |
| 2 | ZIDOVUDINE | 8 | 0.0008 |
| 3 | LAMIVUDINE | 18 | 0.0007 |
| 4 | RALTEGRAVIR | 2 | 0.0004 |
| 5 | CANDESARTAN | 1 | 0.0000 |
| 6 | EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE | 1 | 0.0000 |
| 7 | BISOPROLOL FUMARATE | 1 | 0.0000 |
| 8 | ASPIRIN | 1 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 19 | 0.0004 |
| 1 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 21 | 0.0002 |
| 2 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 1 | 0.0000 |
| 3 | Platelet Aggregation Inhibitor [EPC] | 1 | 0.0000 |
| 4 | Nonsteroidal Anti-inflammatory Drug [EPC] | 1 | 0.0000 |